Byron D. Elliott, M.D. Medical Director of Perinatology Seton Medical Center
Byron D. Elliott, M.D. Medical Director of Perinatology Seton Medical Center
Byron D. Elliott, M.D. Medical Director of Perinatology Seton Medical Center
Occurs more commonly than any other medical problem in pregnancy Overall incidence is 1 - 2.5% in those receiving UNIVERSAL SCREENING and treatment of asymptomatic bacteriuria (ASB) As high as 40% of pregnancies with untreated ASB will develop pyelonephritis
Risk of recurrence in same pregnancy as high as 10 -18% with suppressive therapy Recurrence as high as 60% if ongoing suppressive therapy is not employed
Coexistent factors:
Urinary anomalies, calculi, multiple UTIs Dehydration, poor hygiene Resistant organisms, Rx noncompliance Diabetes, Sickle disease
Clinical Findings:
Fever, chills, malaise CVA pain/tenderness, dysuria, frequency 50% unilateral right sided flank pain 25% bilateral or unilateral left sided pain
Pyuria, bacteriuria White blood cell casts highly predictive Positive urine culture 10 20% bacteremic
Laboratory Findings:
Mild / Moderate Low-grade Fever Normal or slightly elevated white blood cell count Absence of Nausea or Vomiting
Outpatient management after inpatient observation and initial parenteral Rx. can be considered with 14 day oral antibiotic therapy
Severe High Fever Respiratory Insufficiency Poor urine output Sepsis Unable to tolerate oral intake or antibiotics No improvement during initial / observational phase
Inpatient observation Intravenous hydration, Lactated Ringers Strict I & O, Maintain output >30-50cc/hr Parenteral antibiotics Laboratory / Diagnostic Tests:
CBC, electrolytes, creatinine, urinalysis,
urine culture and sensitivities CXR, pulse oximetry, ABGs if respiratory symptoms present
Parenteral
Ceftriaxone
Cefotetan Cefotaxime
Ampicillin and
1-2gm q 24h 2gm q 12h 1-2gm q 8h 2gm q 6h 3-5mg/kg/day 1.5gm q 6h 3.75gm q 6-8h
Oral
Amoxicillin/Clavulanate
Bactrim DS
Suppression post-treatment
Nitrofurantoin
100mg hs
Multi-organ system involvement in 20% Anemia due to hemolysis in up to 66% DIC with severe sepsis Transient renal dysfunction in 20% ARDS in 2 8%, especially with:
Tachycardia >110 BPM Fever >103 in first 24 hours Fluid overload Tocolytic therapy
Preterm Labor
Treatment of Preterm labor in pyelonephritis with tocolytic therapy and steroids should be undertaken with great caution. Only for documented cervical change and regular uterine contractions unresponsive to hydration and parenteral antibiotics. Withholding tocolytics and/or steroids is appropriate in certain circumstances in patients with respiratory or hemodynamic instability.
Maintain lower core temperature secondary to increased risk of fetal anomalies in high fever scenario
Preventative Measures:
Universal screening for ASB Treatment of ASB
Initial Treatment:
In-hospital observation for 24h Parenteral antibiotics Laboratory work-up Hydration to maintain urine output >30-50cc/hr Strict I & O CXR, ABG, Oximetry if respiratory symptoms present
Mild/Moderate Pyelonephritis:
Initial hospital observation and work-up Parenteral antibiotics until discharge 14 day course of oral antibiotics Test of cure
Inpatient management Parenteral antibiotics Strict fluid management Support of secondary organ system involvement
Severe Pyelonephritis
Tocolytics only when clearly indicated by cervical change, and uterine contractions not resolved by hydration and antibiotic therapy